CO4700420A1 - Formulacion transdermica - Google Patents

Formulacion transdermica

Info

Publication number
CO4700420A1
CO4700420A1 CO96003054A CO96003054A CO4700420A1 CO 4700420 A1 CO4700420 A1 CO 4700420A1 CO 96003054 A CO96003054 A CO 96003054A CO 96003054 A CO96003054 A CO 96003054A CO 4700420 A1 CO4700420 A1 CO 4700420A1
Authority
CO
Colombia
Prior art keywords
formulation
transdermic
xanomelina
weight
parts
Prior art date
Application number
CO96003054A
Other languages
English (en)
Spanish (es)
Inventor
Franklin Porter Bymaster
Michael Horstmann
Harlan Edgar Shannon
Lisa Ann Shipley
Kirti Himatlal Valia
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of CO4700420A1 publication Critical patent/CO4700420A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CO96003054A 1995-01-30 1996-01-25 Formulacion transdermica CO4700420A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US38047895A 1995-01-30 1995-01-30

Publications (1)

Publication Number Publication Date
CO4700420A1 true CO4700420A1 (es) 1998-12-29

Family

ID=23501315

Family Applications (1)

Application Number Title Priority Date Filing Date
CO96003054A CO4700420A1 (es) 1995-01-30 1996-01-25 Formulacion transdermica

Country Status (23)

Country Link
US (1) US5980933A (enExample)
EP (1) EP0723781A3 (enExample)
JP (1) JPH10513181A (enExample)
KR (1) KR19980701730A (enExample)
AR (1) AR001790A1 (enExample)
AU (1) AU709379B2 (enExample)
BR (1) BR9600216A (enExample)
CA (1) CA2210711A1 (enExample)
CO (1) CO4700420A1 (enExample)
CZ (1) CZ240297A3 (enExample)
EA (1) EA001083B1 (enExample)
HU (1) HUP9800832A3 (enExample)
IL (1) IL116895A (enExample)
NO (1) NO973471L (enExample)
NZ (1) NZ301197A (enExample)
PE (1) PE17397A1 (enExample)
PL (1) PL321686A1 (enExample)
RO (1) RO117146B1 (enExample)
TR (1) TR199700711T1 (enExample)
TW (1) TW304167B (enExample)
WO (1) WO1996023463A1 (enExample)
YU (1) YU5196A (enExample)
ZA (1) ZA96530B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0821956A1 (en) * 1996-08-01 1998-02-04 Eli Lilly And Company Method for treating disruptive behavior disorders
US6090829A (en) * 1996-08-01 2000-07-18 Eli Lilly And Company Method for treating excessive aggression
EP0821954A1 (en) * 1996-08-01 1998-02-04 Eli Lilly And Company Method for treating mental retardation
US6043258A (en) * 1996-08-01 2000-03-28 Eli Lilly And Company Method for treating disruptive behavior disorders with xanomeline
US6117890A (en) * 1996-08-01 2000-09-12 Eli Lilly And Company Method for treating bipolar disorder
WO1998027903A1 (en) * 1996-12-20 1998-07-02 Johnson & Johnson Inc. Sanitary absorbent article with positioning flaps capable of gathering the undergarment to protect against wetting
US6034108A (en) * 1997-07-28 2000-03-07 Eli Lilly And Company Method for treating mental retardation
US6193993B1 (en) 1998-03-03 2001-02-27 Eisai Co., Ltd. Suppository containing an antidementia medicament
US6528529B1 (en) 1998-03-31 2003-03-04 Acadia Pharmaceuticals Inc. Compounds with activity on muscarinic receptors
JP5106715B2 (ja) * 1999-09-24 2012-12-26 アルロン・ジャパン株式会社 Ｌ−アスコルビン酸、ｌ−アスコルビン酸誘導体の皮膚真皮層への放出方法に使用するための組成物
JP3962684B2 (ja) * 2000-11-06 2007-08-22 サムヤン コーポレイション 改善された水分吸収能および接着性を有する経皮投与剤
EP2275096A3 (en) 2005-08-26 2011-07-13 Braincells, Inc. Neurogenesis via modulation of the muscarinic receptors
EP2258357A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
DE102005050431A1 (de) * 2005-10-21 2007-04-26 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Verabreicherung lipophiler und/oder wenig hautpermeabler Wirkstoffe
US20070259859A1 (en) * 2006-05-04 2007-11-08 De Bruin Natasja M W J Muscarinic agonists to treat impulse control disorders
DE102010024105A1 (de) * 2010-06-17 2011-12-22 Grünenthal GmbH Transdermale Verabreichung von Memantin
WO2012094360A2 (en) 2011-01-04 2012-07-12 Gordon Chiu Biotherapeutics for the treatment of infectious diseases
EP3265067A4 (en) 2015-03-06 2018-09-12 Chase Pharmaceuticals Corporation Oxybutynin-xanomeline transdermal therapeutic system combinations
WO2017044693A1 (en) 2015-09-11 2017-03-16 Chase Pharmaceuticals Corporation Muscarinic combination and its use for combating hypocholinergic disorders of the central nervous system
DE102017127452A1 (de) * 2017-11-21 2019-05-23 Lts Lohmann Therapie-Systeme Ag Wasserlösliche Polymerklebschichten

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4316893A (en) * 1975-06-19 1982-02-23 Nelson Research & Development Co. Vehicle composition containing 1-substituted azacycloalkan-2-ones
US5344656A (en) * 1986-09-12 1994-09-06 Alza Corporation Subsaturated transdermal therapeutic system having improved release characteristics
US4908027A (en) * 1986-09-12 1990-03-13 Alza Corporation Subsaturated transdermal therapeutic system having improved release characteristics
MY102980A (en) * 1986-10-31 1993-03-31 Pfizer Transdermal flux enhancing compositions
ES2037230T3 (es) * 1987-08-28 1993-06-16 Eli Lilly And Company Composiciones activadoras de la penetracion.
IT1233860B (it) * 1988-02-08 1992-04-21 Isf Spa Derivati del peridroazacicloalca (1,2-a) imidazolo ad attivita' nootropa
DE3843239C1 (enExample) * 1988-12-22 1990-02-22 Lohmann Therapie Syst Lts
US5043345A (en) * 1989-02-22 1991-08-27 Novo Nordisk A/S Piperidine compounds and their preparation and use
IE82916B1 (en) * 1990-11-02 2003-06-11 Elan Corp Plc Formulations and their use in the treatment of neurological diseases
DK198590D0 (da) * 1990-08-21 1990-08-21 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling og anvendelse
US5238933A (en) * 1991-10-28 1993-08-24 Sri International Skin permeation enhancer compositions

Also Published As

Publication number Publication date
ZA96530B (en) 1997-07-23
EP0723781A3 (en) 1996-08-07
HUP9800832A2 (hu) 1999-01-28
EA001083B1 (ru) 2000-10-30
MX9705723A (es) 1997-11-29
BR9600216A (pt) 1998-01-06
PE17397A1 (es) 1997-05-21
YU5196A (sh) 1998-08-14
TR199700711T1 (xx) 1998-01-21
US5980933A (en) 1999-11-09
CZ240297A3 (cs) 1998-04-15
HUP9800832A3 (en) 2000-07-28
EP0723781A2 (en) 1996-07-31
CA2210711A1 (en) 1996-08-08
NO973471L (no) 1997-09-19
RO117146B1 (ro) 2001-11-30
EA199700151A1 (ru) 1997-12-30
AU4656596A (en) 1996-08-21
KR19980701730A (ko) 1998-06-25
WO1996023463A1 (en) 1996-08-08
TW304167B (enExample) 1997-05-01
AR001790A1 (es) 1997-12-10
NO973471D0 (no) 1997-07-28
IL116895A (en) 2000-08-31
JPH10513181A (ja) 1998-12-15
NZ301197A (en) 1999-09-29
AU709379B2 (en) 1999-08-26
PL321686A1 (en) 1997-12-22
IL116895A0 (en) 1996-05-14

Similar Documents

Publication Publication Date Title
ES2155931T3 (es) Forma de administracion de un agente activo de liberacion prolongada en banda.
MX9202328A (es) Composicion farmaceutica local que contiene un compuesto alilamina como el agente activo.
ES2082828T3 (es) Pesticida de azol.
DE69942154D1 (de) Medikamenthaltige zusammensetzung in aerosolform
BR0007147A (pt) Composição de tensìdio contendo tensìdio gemini e co-anfifila, sua preparação e aplicação
AU2001236744A1 (en) Delivery system for topical skin care agents
NO970361D0 (no) Spraybart filmdannende system som frigjör aktive stoffer for anvendelse på planter
ES2170158T3 (es) Composiciones topicas que contienen n-acetil-l-cisteina.
DE69635987D1 (de) Verbesserte liposomale formulierung
ATE60900T1 (de) Tensidepraeparate.
IT8022622A0 (it) Formulazioni stabili di n-(3,4-diclorofenil)-n'-metossi-n'metilurea (linorun)e 2,6-dinitro-n,n-dipropil-4-trifluorometilanilina (trifluralin) in emulsione.
DK1189595T3 (da) Ophthalmiske sammensætninger i form af vandige geler
AR001399A1 (es) Una composición acondicionadora del cabello.
AR004077A1 (es) Una composicion particularmente cosmetica, y mas particularmente para la deformacion permanente de las fibras queratinicas.
PA8459501A1 (es) Formulaciones parasiticidas
CO4750591A1 (es) Procedimiento de lucha contra los insectos
DK0613368T3 (da) Hudregenererende kosmetisk sammensætning
MX9304456A (es) Composiciones pesticidas estables en almacenamiento que comprenden azadiractina y epoxido.
AR014325A1 (es) Uso de glicinas n,n'-disustituidos o derivados de los mismos como desinfectantes antituberculosos y los desinfectantes antituberculososformulados con dichas glicinas n,n'-disustituidos
FI971833A0 (fi) Lapsiturvallinen pakkaus vaikuttavaa ainetta sisältävää laastaria varten
BR9802803A (pt) ação e composições farmacêuticas contendo os mesmos.
ES2117362T3 (es) Composicion cosmetica o farmaceutica que contiene un carbamato de alquilo como agente hidratante.
AR006860A1 (es) Mezclas fungicidas sinergicas, util para combatir hongos fitopatogenos y su procedimiento de aplicacion
MA26447A1 (fr) Analogues peptidiques de la lh-rh, leurs utilisations et compositions pharmaceutiques en contenant
ES2059756T3 (es) Composiciones farmaceuticas que contienen primicina.